-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TM9jho/plYTT2bvhY2KTQXFwnVSbxoB3JY89z70wn1C79e4RP2gUazmbXqwLFx0l U0hB4JIc+Da/08jVIN31Wg== 0000932471-07-000491.txt : 20070214 0000932471-07-000491.hdr.sgml : 20070214 20070214123737 ACCESSION NUMBER: 0000932471-07-000491 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070214 DATE AS OF CHANGE: 20070214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-56595 FILM NUMBER: 07616720 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: VANGUARD HORIZON FUNDS CENTRAL INDEX KEY: 0000932471 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 232787277 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: P O BOX 2600 STREET 2: V26 CITY: VALLEY FORGE STATE: PA ZIP: 19482 BUSINESS PHONE: 6106696295 MAIL ADDRESS: STREET 1: P.O. BOX 2600 STREET 2: V26 CITY: VALLEY FORGE STATE: PA ZIP: 19482 FORMER COMPANY: FORMER CONFORMED NAME: VANGUARD HORIZON FUND INC DATE OF NAME CHANGE: 19941107 SC 13G/A 1 biomarin.htm AMENDMENT 3

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Schedule 13G

 

Under the Securities Exchange Act of 1934

(Amendment No.:3 )*

 

 

Name of issuer:  BIOMARIN PHARMACEUTICALS INC

 

Title of Class of Securities:  Common Stock

 

CUSIP Number:  09061G101

 

Date of Event Which Requires Filing of this Statement: December 31, 2006

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 (X) Rule 13d-1(b)

 ( ) Rule 13d-1(c)

 ( ) Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

(Continued on the following page(s))

 

 

 

 

 

 

 

 

 

 

 

 

 13G

 

CUSIP No.: 09061G101

 

1. NAME OF REPORTING PERSON

 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

 

VANGUARD HORIZON FUNDS - VANGUARD CAPITAL OPPORTUNITY FUND   23-2801531

 

2. CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

 

A.

B. X

 

3. SEC USE ONLY

 

4. CITIZENSHIP OF PLACE OF ORGANIZATION

 

  Delaware

 

(For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

 

5. SOLE VOTING POWER

 

  4670500

 

6. SHARED VOTING POWER

 

  0

 

7. SOLE DISPOSITIVE POWER

 

  0

 

8. SHARED DISPOSITIVE POWER

 

  0

 

9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  4670500

 

10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

  N/A

 

11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  5.11 %

 

12. TYPE OF REPORTING PERSON

 

  IV

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

__________

 

SCHEDULE 13G

Under the Securities Act of 1934

__________

 

Check the following [line] if a fee is being paid with this statement   N/A

 

Item 1(a) - Name of Issuer:

 

  BIOMARIN PHARMACEUTICALS INC

 

Item 1(b) - Address of Issuer's Principal Executive Offices:

 

  105 DIGITAL DRIVE

  NOVATO, CA 94949

 

Item 2(a) - Name of Person Filing:

 

VANGUARD HORIZON FUNDS - VANGUARD CAPITAL OPPORTUNITY FUND   23-2801531

 

Item 2(b) – Address of Principal Business Office or, if none, residence:

 

   100 Vanguard Blvd.

   Malvern, PA 19355

 

Item 2(c) – Citizenship:

 

  Delaware

 

Item 2(d) - Title of Class of Securities:

 

  Common Stock

 

Item 2(e) - CUSIP Number

 

  09061G101

 

Item 3 - Type of Filing:

 

This statement is being filed pursuant to Rule 13d-1. Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

 

Item 4 - Ownership:

 

 (a) Amount Beneficially Owned:

 

  4670500

 

 (b) Percent of Class:

 

 

  5.11%

 

 

 (c) Number of shares as to which such person has:

 

   (i) sole power to vote or direct to vote: 4670500

 

   (ii) shared power to vote or direct to vote: 0

 

   (iii) sole power to dispose of or to direct the disposition of:  0

 

   (iv) shared power to dispose or to direct the disposition of:  0

 

Item 5 - Ownership of Five Percent or Less of a Class:

 

 Not applicable

 

Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

 

 Not applicable

 

Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

 

 Not applicable

 

Item 8 - Identification and Classification of Members of Group:

 

 Not applicable

 

Item 9 - Notice of Dissolution of Group:

 

 Not applicable

 

Item 10 - Certification:

 

By signing below I certify than, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect.

 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

Date:    11/30/2006  

By /s/ Arthur S. Gabinet

 

Arthur S. Gabinet

 

Assistant Secretary

 

 

 

-----END PRIVACY-ENHANCED MESSAGE-----